FDA inspection
GlaxoWellcome Production: FDA inspection ending Feb 27, 2012
FDA inspection 772742 · No Action Indicated (NAI) · Evreux
Key facts
| Inspection ID | 772742 |
|---|---|
| Firm | GlaxoWellcome Production |
| FEI number | 3002807436 |
| Address | Zone Industrielle 2, 23 Rue Lavoisier |
| City | Evreux |
| Country | France |
| Fiscal year | 2012 |
| Inspection end date | Feb 27, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data